Precision Oncology in Gastrointestinal Stromal Tumors

por Mechahougui, Hiba, Michael, Montemurro, Friedlaender, Alex
Publicado 2023

New emerging targets in cancer immunotherapy: the role of TIM3

por Friedlaender, Alex, Addeo, Alfredo, Banna, Giuseppe
Publicado 2019

Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic

por Friedlaender, Alex, Kim, Chul, Addeo, Alfredo
Publicado 2020

COVID-19 and lung cancer: risks, mechanisms and treatment interactions

por Addeo, Alfredo, Obeid, Michel, Friedlaender, Alex
Publicado 2020

The Role and Impact of Minimal Residual Disease in NSCLC

por Frisone, Daniele, Friedlaender, Alex, Addeo, Alfredo
Publicado 2021

Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung Cancer

por Baudoux, Nathalie, Friedlaender, Alex, Addeo, Alfredo
Publicado 2023

Tarlatamab: a potential new option for recurrent small cell lung cancer

por Addeo, Alfredo, Banna, Giuseppe Luigi, Friedlaender, Alex
Publicado 2023

Tracking the tail

por Friedlaender, Alex, Liu, Stephen V, Addeo, Alfredo
Publicado 2020

KRAS G12C Mutations in NSCLC: From Target to Resistance

por Addeo, Alfredo, Banna, Giuseppe Luigi, Friedlaender, Alex
Publicado 2021

Stepping in the right direction but still some ways to go

por Addeo, Alfredo, Banna, Giuseppe Luigi, Friedlaender, Alex
Publicado 2019

Pleural Mesothelioma in the Era of Immunotherapy

por Chevallier, Mathieu, Kim, Floryane, Friedlaender, Alex, Addeo, Alfredo
Publicado 2023

Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer

por Mederos, Nuria, Friedlaender, Alex, Peters, Solange, Addeo, Alfredo
Publicado 2020

Oncogenic driver mutations in non-small cell lung cancer: Past, present and future

por Chevallier, Mathieu, Borgeaud, Maxime, Addeo, Alfredo, Friedlaender, Alex
Publicado 2021

The Landscape of Immunotherapy Resistance in NSCLC

por Frisone, Daniele, Friedlaender, Alex, Addeo, Alfredo, Tsantoulis, Petros
Publicado 2022

Identifying successful biomarkers for patients with non-small-cell lung cancer

por Friedlaender, Alex, Bauml, Joshua, Banna, Giuseppe Luigi, Addeo, Alfredo
Publicado 2019

How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere

por Banna, Giuseppe, Curioni-Fontecedro, Alessandra, Friedlaender, Alex, Addeo, Alfredo
Publicado 2020

Reply to Authors

por Banna, Giuseppe, Curioni-Fontecedro, Alessandra, Friedlaender, Alex, Addeo, Alfredo
Publicado 2020

Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature Review

por Chevallier, Mathieu, Chevallier-Lugon, Chloé, Friedlaender, Alex, Addeo, Alfredo
Publicado 2021

Cellular Therapy in NSCLC: Between Myth and Reality

por Imbimbo, Martina, Wetterwald, Laureline, Friedlaender, Alex, Parikh, Kaushal, Addeo, Alfredo
Publicado 2023

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

por Friedlaender, Alex, Banna, Giuseppe, Malapelle, Umberto, Pisapia, Pasquale, Addeo, Alfredo
Publicado 2019